Treatment of Bronchiectasis in Adults

Overview

Journal BMJ

Specialty General Medicine

Date 2007 Nov 24

PMID 18033931

Citations 11

Authors

Nick H T Ten Hacken

Peter J Wijkstra

Huib A M Kerstjens

Affiliations

Soon will be listed here.

Citing Articles

Videothoracoscopic lobectomy for bronchiectasis and extrapulmonary sequestration in a case Kartagener syndrome with pectus excavatum.

Aydogmus U Turk Gogus Kalp Damar Cerrahisi Derg. 2022; 29(4):549-551.

PMID: 35096455 PMC: 8762916. DOI: 10.5606/tgkdc.dergisi.2021.19939.

Quality of life in patients with bronchiectasis: a 2-year longitudinal study.

Magge A, Ashraf S, Quittner A, Metersky M Ann Transl Med. 2019; 7(14):334.

PMID: 31475204 PMC: 6694265. DOI: 10.21037/atm.2019.06.62.

Brazilian consensus on non-cystic fibrosis bronchiectasis.

Pereira M, Athanazio R, Dalcin P, Figueiredo M, Gomes M, Freitas C J Bras Pneumol. 2019; 45(4):e20190122.

PMID: 31411280 PMC: 6733718. DOI: 10.1590/1806-3713/e20190122.

Cardiorespiratory Responses to Glittre ADL Test in Bronchiectasis: A Cross-Sectional Study.

Hena R, Alaparthi G, Shyam Krishnan K, Anand R, Acharya V, Acharya P Can Respir J. 2019; 2018:7470387.

PMID: 30651896 PMC: 6311838. DOI: 10.1155/2018/7470387.

Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.

Li W, Qin Z, Gao J, Jiang Z, Chai Y, Guan L Chron Respir Dis. 2018; 16:1479972318790269.

PMID: 30101613 PMC: 6302979. DOI: 10.1177/1479972318790269.

References

Jones A, Rowe B . Bronchopulmonary hygiene physical therapy in bronchiectasis and chronic obstructive pulmonary disease: a systematic review. Heart Lung. 2000; 29(2):125-35. View

Barker A, Couch L, Fiel S, Gotfried M, Ilowite J, Meyer K . Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med. 2000; 162(2 Pt 1):481-5. DOI: 10.1164/ajrccm.162.2.9910086. View

Jones A, Rowe B . Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis. Cochrane Database Syst Rev. 2000; (2):CD000045. DOI: 10.1002/14651858.CD000045. View

Orriols R, Roig J, Ferrer J, Sampol G, Rosell A, Ferrer A . Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa. Respir Med. 1999; 93(7):476-80. DOI: 10.1016/s0954-6111(99)90090-2. View

Corless J, Warburton C . Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis. Cochrane Database Syst Rev. 2000; (4):CD002174. PMC: 8406951. DOI: 10.1002/14651858.CD002174. View

Kolbe J, Wells A, Ram F . Inhaled steroids for bronchiectasis. Cochrane Database Syst Rev. 2000; (2):CD000996. DOI: 10.1002/14651858.CD000996. View

COLE P . Inflammation: a two-edged sword--the model of bronchiectasis. Eur J Respir Dis Suppl. 1986; 147:6-15. View

Dogan R, Alp M, Kaya S, Ayrancioglu K, Tastepe I, Unlu M . Surgical treatment of bronchiectasis: a collective review of 487 cases. Thorac Cardiovasc Surg. 1989; 37(3):183-6. DOI: 10.1055/s-2007-1020314. View

Wills P, Wodehouse T, Corkery K, Mallon K, Wilson R, COLE P . Short-term recombinant human DNase in bronchiectasis. Effect on clinical state and in vitro sputum transportability. Am J Respir Crit Care Med. 1996; 154(2 Pt 1):413-7. DOI: 10.1164/ajrccm.154.2.8756815. View

10.

Lasserson T, Holt K, Greenstone M . Oral steroids for bronchiectasis (stable and acute exacerbations). Cochrane Database Syst Rev. 2001; (4):CD002162. PMC: 8407352. DOI: 10.1002/14651858.CD002162. View

11.

Evans D, Bara A, Greenstone M . Prolonged antibiotics for purulent bronchiectasis. Cochrane Database Syst Rev. 2003; (4):CD001392. DOI: 10.1002/14651858.CD001392. View

12.

Harbour R, Miller J . A new system for grading recommendations in evidence based guidelines. BMJ. 2001; 323(7308):334-6. PMC: 1120936. DOI: 10.1136/bmj.323.7308.334. View

13.

Franco F, Sheikh A, Greenstone M . Short acting beta-2 agonists for bronchiectasis. Cochrane Database Syst Rev. 2003; (3):CD003572. DOI: 10.1002/14651858.CD003572. View

14.

Lasserson T, Holt K, Evans D, Greenstone M . Anticholinergic therapy for bronchiectasis. Cochrane Database Syst Rev. 2001; (4):CD002163. PMC: 8407497. DOI: 10.1002/14651858.CD002163. View

15.

Steele K, Greenstone M, Lasserson J . Oral methyl-xanthines for bronchiectasis. Cochrane Database Syst Rev. 2001; (1):CD002734. PMC: 8406678. DOI: 10.1002/14651858.CD002734. View

16.

Wills P, Greenstone M . Inhaled hyperosmolar agents for bronchiectasis. Cochrane Database Syst Rev. 2002; (1):CD002996. DOI: 10.1002/14651858.CD002996. View

17.

Corless J, Warburton C . Surgery vs non-surgical treatment for bronchiectasis. Cochrane Database Syst Rev. 2000; (4):CD002180. PMC: 8407459. DOI: 10.1002/14651858.CD002180. View

18.

Sheikh A, Nolan D, Greenstone M . Long-acting beta-2-agonists for bronchiectasis. Cochrane Database Syst Rev. 2001; (4):CD002155. PMC: 8407186. DOI: 10.1002/14651858.CD002155. View

19.

Cymbala A, Edmonds L, Bauer M, Jederlinic P, May J, Victory J . The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis. Treat Respir Med. 2005; 4(2):117-22. DOI: 10.2165/00151829-200504020-00005. View

20.

Pasteur M, Helliwell S, Houghton S, Webb S, Foweraker J, Coulden R . An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000; 162(4 Pt 1):1277-84. DOI: 10.1164/ajrccm.162.4.9906120. View